Striatal DA synaptic vesicles from PD patients were also found to have lower levels of VMAT2 (Pifl et al., 2014), although as these patients were almost certainly treated with L-DOPA, a decrease in VMAT expression could be a compensatory response rather than a cause of PD. Here, SLC18A2 is linked to Parkinson disease.